A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease
Clinical trial NCT01114503 · TERMINATED
Trial details
- NCT number
- NCT01114503
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-07
- Primary completion
- 2012-08-29
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.